537 related articles for article (PubMed ID: 30543927)
1. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
[TBL] [Abstract][Full Text] [Related]
2. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.
Honnorat J; Antoine JC; Derrington E; Aguera M; Belin MF
J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):270-8. PubMed ID: 8795598
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
[TBL] [Abstract][Full Text] [Related]
6. [Autoantibodies in Paraneoplastic Neurological Syndrome].
Kawachi I
Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281
[TBL] [Abstract][Full Text] [Related]
7. Multiplex serology of paraneoplastic antineuronal antibodies.
Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA
J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
9. Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes.
Berger B; Stich O; Labeit S; Rauer S
J Neuroimmunol; 2016 Jun; 295-296():18-20. PubMed ID: 27235344
[TBL] [Abstract][Full Text] [Related]
10. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of paraneoplastic neurological syndromes].
Tanaka K
Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
[TBL] [Abstract][Full Text] [Related]
12. Systemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease.
Moll JW; Hooijkaas H; van Goorbergh BC; Roos LG; Henzen-Logmans SC; Vecht CJ
J Neurol; 1996 Jan; 243(1):51-6. PubMed ID: 8869387
[TBL] [Abstract][Full Text] [Related]
13. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches in antibody-associated central nervous system pathologies.
Honnorat J
Rev Neurol (Paris); 2014 Oct; 170(10):587-94. PubMed ID: 25189679
[TBL] [Abstract][Full Text] [Related]
15. [Limbic encephalitis with antibodies against intracellular antigens].
Morita A; Kamei S
Brain Nerve; 2010 Apr; 62(4):347-55. PubMed ID: 20420174
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in neurological paraneoplastic diseases.
Lövblad KO; Boucraut J; Lehmann HP; Stahel R; Regli F; Steck AJ
Schweiz Arch Neurol Psychiatr (1985); 1994; 145(3):3-7. PubMed ID: 7533934
[TBL] [Abstract][Full Text] [Related]
17. Avidity of onconeural antibodies is of clinical relevance.
Totland C; Ying M; Haugen M; Mazengia K; Storstein A; Aarseth J; Martinez A; Vedeler C
Cancer Immunol Immunother; 2013 Aug; 62(8):1393-6. PubMed ID: 23733227
[TBL] [Abstract][Full Text] [Related]
18. Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors.
Antoine JC; Absi L; Honnorat J; Boulesteix JM; de Brouker T; Vial C; Butler M; De Camilli P; Michel D
Arch Neurol; 1999 Feb; 56(2):172-7. PubMed ID: 10025422
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases.
Benyahia B; Amoura Z; Rousseau A; Le Clanche C; Carpentier A; Piette JC; Delattre JY
J Neurooncol; 2003 May; 62(3):349-51. PubMed ID: 12777089
[TBL] [Abstract][Full Text] [Related]
20. Which antibody and which cancer in which paraneoplastic syndromes?
Gozzard P; Maddison P
Pract Neurol; 2010 Oct; 10(5):260-70. PubMed ID: 20858627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
